Agios Pharmaceuticals (AGIO) Preferred Dividend Payments (2012 - 2013)
Agios Pharmaceuticals (AGIO) posted Preferred Dividend Payments of $567000.0 for Q3 2013, down 68.46% on a QoQ basis from $1.8 million in Q2 2013, and up 131.54% year-over-year from $244887.3 in Q3 2012.
Agios Pharmaceuticals (AGIO) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Agios Pharmaceuticals' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $567000.0 for Q3 2013.
- Quarterly Preferred Dividend Payments rose 131.54% year-over-year to $567000.0 in Q3 2013, while the trailing twelve-month figure through Dec 2013 was $4.2 million (changed N/A YoY) and the FY2013 annual result came in at $4.2 million, down 42.11% from the prior year.
- Preferred Dividend Payments was $567000.0 for Q3 2013 at Agios Pharmaceuticals, down from $1.8 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $12.6 million in Q4 2012 and bottomed at -$1.8 million in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agios Pharmaceuticals | 2.13 Bn | 2.13 Bn | 19.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 567,000.00 |
| Jun 30, 2013 | 1.80 Mn |
| Mar 31, 2013 | 1.80 Mn |
| Dec 31, 2012 | 12.58 Mn |
| Sep 30, 2012 | -1.80 Mn |
| Jun 30, 2012 | 1.80 Mn |